ClinicalTrials.gg
CompletedNCT07438990Updated Aug 26, 2026

Evaluation of the Whitening Effect in Subjects After Professional Tooth Cleaning Procedure

An interventional study of Whitening toothpaste and Regular toothpaste in Tooth Color, sponsored by Lacer S.A.. Completed at 1 site in Spain. Open to participants aged 18 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-08-26.

Sponsored by Lacer S.A. (part of Italfarmaco) · Not applicable, Interventional, and Other

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
56
Allocation
Randomized
Ages
18 Years to 65 Years
Sex
All
01

Study summary

The goal of this study is to learn if the toothpaste works to maintain effect of the professional tooth cleaning in adults. It will also learn about the safety of the product. The main questions it aims to answer are:

  • Does the toothpaste help to maintain teeth colour after professional cleaning?

Researchers will compare whitening toothpaste to a regular toothpaste to see if it works to maintain effects of professional teeth cleaning.

Participants will:

  • Use assigned toothpaste daily for 4 weeks
  • Visit the clinic on the established days during 4 weeks for check ups and evaluation
02

Conditions studied

  • Tooth Color
03

In context

Lead sponsor

Lacer S.A. is the lead sponsor of 13 studies on the registry; 3 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Healthy 55 subjects
  2. Subjects of caucasian ethnicity
  3. Subjects aged between 18 and 65 years (extremes included)
  4. Subjects clinically showing stains on teeth (due to smoking, tea, coffee, wine or other food that typically stain teeth)
  5. Subjects having at least one natural teeth or central superior incisors (tooth 11 and 21) with color shade at the inclusion ≥12 and ≤30 according to R20 Bleaching shade guide
  6. Subjects registered with National Health Service (NHS)
  7. Subjects certifying the truthfulness of the personal data disclosed to the Principal Investigator or designated personnel
  8. Subjects able to understand the language used in the investigation center and the information given by the Principal Investigator or designated personnel
  9. Subjects able to respect the instructions given by the Principal Investigator or designated personnel as well as able to respect the study constraints and specific requirements
  10. Subjects who commit not to change their daily routine or lifestyle during the study
  11. Subjects on stable pharmacological therapy (except for the pharmacological therapy in the non-inclusion criteria) for at least one month without any changes expected or planned during the study
  12. Subjects informed about the test procedures who have signed a consent form and privacy agreement

Exclusion criteria

Exclusion Criteria:

  1. Subjects who do not meet the inclusion criteria.
  2. Subjects with all affection which could interfere with the interpretation of the results of the study
  3. Subjects planning toothcare during the study period, using dental apparatus
  4. Subjects using dental prosthesis affecting the central superior incisors, with generalized tooth recession, malocclusion or overlapping teeth in the anterior region, with presence of caries, with dental abscess or untreated gum disease, with central superior incisor (tooth 11 or 21) evaluated and filled and who performed whitening treatments less than 6 months before the study begin
  5. Subjects with any acute, chronic, or progressive disease or condition that may interfere with the study data or that the Principal Investigator considers dangerous to the subject or incompatible with the requirements of the study
  6. Subjects participating or planning to participate in other clinical trials
  7. Subjects who participated in a similar study without respecting an adequate (at least one month)
  8. Subjects that have intolerances or allergies to ingredients of the study product
  9. Subjects under pharmacological treatments that are considered incompatible with the study requirement by the Principal Investigator
  10. Subjects who are currently using products with the same activity as the study product, or who haven't observed an adequate washout period (at least one month)
  11. Subjects admitted to a health or social facility
  12. Subjects planning a hospitalization during the study
  13. Subjects not able to be contacted in case of emergency
  14. Subjects deprived of freedom by administrative or legal decision or under guardianship
  15. Subjects who have or have had a history of alcohol or drug addiction
  16. Subject breastfeeding, pregnant or not willing to take necessary precautions to avoid pregnancy during the study (for the women of ).
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Washout period

A planned gap after a treatment, so that its effects can lessen before the study treatment or a study assessment. Ask the study team and the doctor who prescribed it before changing any medicine.

Childbearing potential

Able to become pregnant: from the first period until menopause, unless permanently unable to through surgery (removal of the womb, or of both ovaries or both fallopian tubes).

Criteria for people of childbearing potential usually ask for a negative pregnancy test and for contraception during the study and for a time after it.

05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Investigator)
Enrollment
56 participants (actual)

Study arms

  • Experimental
    Whitening toothpaste

    Whitening toothpaste will be used 3 times a day during 28 days after teeth cleaning procedure.

    Other: Whitening toothpaste

  • Active comparator
    Regular toothpaste

    Regular toothpaste will be used 3 times a day during 28 days after teeth cleaning procedure.

    Other: Regular toothpaste

Interventions

  • OtherWhitening toothpaste

    Subjects will use the whitening toothpaste 3 times daily during 4 weeks

  • OtherRegular toothpaste

    Subjects will use the regular toothpaste 3 times daily during 4 weeks

06

What researchers measure

Primary outcomes

  1. Change in teeth colour at by R20 Bleaching guide score at 4 weeks

    The score ranges from 2 (lightest shade) to 40 (darkest shade). Improvement in colour means decrease in score number.

    Time frame: From Baseline (after professional teeth cleaning) to end of use at 4 weeks.

Secondary outcomes

  1. Teeth brightness variation evaluated by score at 4 weeks

    The brightness will be evaluated by the score from 1 to 4, where 1 means no variation and 4 means evidant improvement

    Time frame: From Baseline (after professional teeth cleaning) to end of use at 4 weeks.

07

Study locations

1 site
  • Clinica Dental Rob
    Badalona, Catalonia 08917, Spain
08

References and documents

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: No — Only summary of the results to support the publication will be shared. No complete study documents will shared.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Mar 2026 to primary completion in Jun 2026, 3 months.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 18, 2026
First posted
Feb 27, 2026
StartActual
Mar 3, 2026
Primary completionActual
Jun 12, 2026
CompletionActual
Jun 12, 2026
Last update
Aug 26, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 26, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07438990
Lead sponsor
Lacer S.A.
Responsible party
Sponsor
First posted
Feb 27, 2026
Start date
Mar 3, 2026
Primary completion
Jun 12, 2026
Completion
Jun 12, 2026
Last update
Aug 26, 2026

Study contacts

Sonia Robas, Dr
principal investigator · Clinica Dental Rob

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion